Results 141 to 150 of about 11,080 (216)

Point of care INR monitoring in cyanotic congenital heart disease-related compensatory erythrocytosis. [PDF]

Int J Cardiol Congenit Heart Dis
Rueter P, Passam F, Celermajer D, Baker D, Ma Biason C, Osborn D, Cordina R.   +6 more
europepmc   +1 more source

Erythropoietin-Secreting uterine leiomyoma presenting with secondary erythrocytosis: A case report. [PDF]

Gynecol Oncol Rep
Mesa AM, Diggs A, Clark LH.
europepmc   +1 more source

Low neutrophil-to-lymphocyte ratio identifies secondary polycythemia in patients with erythrocytosis. [PDF]

Sci Rep
Yoon SY, Kwon SS, Jeong SY, Lee MY, Kim KH, Kim SH, Bae SB, Lee N, Park SK, Won JH.   +9 more
europepmc   +1 more source

Erythrocytosis

, 2018
Daniel Bell, Michael Hartung
openaire   +1 more source

Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report. [PDF]

Clin Case Rep
Bogojevic M, Medjedovic R, Markovic M, Bakic N, Pravilovic Lutovac D.   +4 more
europepmc   +1 more source

Beyond safety: adverse events and unanticipated advantages of SGLT2 inhibitors. [PDF]

Eur J Clin Pharmacol
Falsetti L, Tarquinio N, Mucci L, Santini S, Guerrieri E, Giovenali L, Pierdomenico G, Zaccone V, Viticchi G, Moroncini G.   +9 more
europepmc   +1 more source

VHL, transferrin, and erythropoietin in the regulation of hepcidin. [PDF]

Hemasphere
Sergeev I, Prchal JT, Nouraie SM, Shah BN, Zhang X, Sergueeva A, Miasnikova G, Ganz T, Gordeuk VR.   +8 more
europepmc   +1 more source

SGLT2i-associated erythrocytosis: closing the evidence gap. [PDF]

Blood Adv
Chin-Yee B, Hsia CC.
europepmc   +1 more source

Modern and multidisciplinary care in polycythemia vera. [PDF]

Ann Hematol
Palandri F, Sartor C, Pileri A, Addimanda O, Gagliardi C, Sartori M, Benni M, Giannella M, Dato FL, Sabattini E, Fiorino L, Dedola A, Branzanti F, Rondinelli MB, Reta M, Galiè N, Viale P, Cosmi B, Placa M, Morelli MC, Zinzani PL.   +20 more
europepmc   +1 more source

Erythrocytosis-inducing PHD2 mutations implicate biological role for N-terminal prolyl-hydroxylation in HIF1α oxygen-dependent degradation domain. [PDF]

Elife
Taber CC, He W, Gasmi-Seabrook GMC, Hubert M, Ferens FG, Ikura M, Lee JE, Ohh M.   +7 more
europepmc   +1 more source